Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The headquarters of the Mahidol Oxford Tropical Medicine Research Unit (MORU) is in Thailand with sister units in Laos, Myanmar, Cambodia and the Democratic Republic of the Congo. MORU is the focal point of the MORU Tropical Health Network (THN), a powerful network of closely linked units, departments, clinical study sites and laboratories that seek to reduce the human disease burden in the tropics by finding practical solutions to major tropical medical problems.

Driven by a coherent joint research agenda, the MORU THN’s current research focuses on malaria, melioidosis, scrub and murine typhus, drug-resistant infections, the causes and treatment of rural fever, sepsis, CNS infections, critical care medicine, maternal and neonatal health, TB and Chagas disease. We have a longstanding interest in medicine quality and in antimicrobial drug resistance, particularly artemisinin resistant falciparum malaria. Our COVID clinical trials network has evolved into the PLATCOV antiviral pharmacodynamic trial, which enables researchers to quickly, with small sample sizes, determine the effectiveness of antiviral drugs.

Learn more about MORU